JPMorgan upgrades Chagee Holdings stock rating on sales recovery By Investing.com

JPMorgan upgraded Chagee Holdings to Overweight and raised its price target to $16.00 (from $11.50), citing improving same-store sales trends and a narrowing of year-to-date 2026 domestic same-store sales declines into the teens from 25.5% in Q4 2025. The company reported Q4 revenue down 11% YoY and a 25.5% YoY drop in same-store GMV, while trading at $9.16 (near a 52-week low of $8.98) and down >60% from its $28 IPO. Key fundamentals include a 2026 estimated P/E of 6.1x, a free cash flow yield of ~12%, a net cash position (more cash than debt) and catalysts of a Korea market entry in April 2026 plus potential shareholder returns (dividends/buybacks). Macquarie cut its PT to $9.30 (Neutral), underscoring mixed analyst views despite JPMorgan's more constructive stance.

Analysis

The market has deeply de-rated this niche China beverage operator, which creates a classic idiosyncratic recovery setup: valuation expansion will come not from macro beta but from operating-leverage beats (store-level throughput and fixed-cost absorption) and credible capital-return signaling. A successful re-rating requires predictable cadence — sequential same-store lifts over 2–3 quarters — because one-off promotions won’t move consensus multiples.

Second-order competitive risks are under-appreciated. International rollouts (e.g., Korea) amplify execution complexity: supply-chain reassortment, localized SKU testing, and added SG&A can temporarily compress margins and raise working capital needs, creating a two- to four-quarter drag even if long-run unit economics hold.

Event and macro tail-risks are asymmetric: a domestic discretionary slowdown or input-cost spike can erase the recovery narrative quickly, while the catalyst path to upside is more binary — a transparent buyback/dividend program or sustained same-store acceleration. That makes this a time- and event-sensitive trade where optionality (low-cost calls, staged equity) beats full-sized outright exposure.

Contrarian frame: consensus is pricing in permanent impairment rather than transitory execution noise. If management converts cash flow into return-of-capital or demonstrates repeatable LFL inflection, upside could compress the implied risk premium by 400–600bps versus peers within 12–18 months. Position sizing should therefore buy optionality ahead of confirmed execution improvement rather than front-load conviction.

Key Decisions for Investors

• Long CHA equity (initial position 0.5% portfolio) — scale in on the first two consecutive quarterly same-store beats or on a confirmed sequential gross-margin recovery; target 2x return in 12–18 months, hard stop at -30% from entry to limit drawdown.
• Long CHA long-dated calls (18–24 month LEAPs, notional 0.25% portfolio) — buy to capture convex upside from multiple expansion while limiting downside; roll or trim if implied volatility compresses after a buyback/dividend announcement.
• Pair trade: long CHA (0.5%) / short KWEB (0.5%) — isolates idiosyncratic retail recovery vs. broad China internet beta; rebalance quarterly and close if CHA underperforms its cohort by >25% over any 3-month window.
• Event-driven catalyst trade: accumulate ahead of the next quarterly release only if management provides explicit capital-return language or three-quarter guidance for LFL stabilization; treat any confirmation as a signal to double equity exposure for a 12–24 month hold.